亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Editorial: 3D-engineered organoids for modelling tissue development and precision medicine

作者
Federica Michielin,Luca Urbani,Camilla Luni,Onelia Gagliano
出处
期刊:Frontiers in chemical engineering [Frontiers Media]
卷期号:6 被引量:1
标识
DOI:10.3389/fceng.2024.1376921
摘要

Organoids are small, self-organized three-dimensional (3D) tissue cultures that reproduce organ structure and function, allowing to mimic physiological and pathological conditions and critical functions of organs. These features enable establishing a simplified, scalable, and accessible approach to address the human tissue availability constraints and the gap between animal models and patients. For this reason, organoid research has dramatically increased over the past decade, to create suitable microscale 3D tissue models that can be used for modelling human development, study disease pathophysiology and for personalized medicine. In vitro tissue engineering enables the creation of 3D organoid-based models with even more advanced properties and structures, and with various degrees of complexity. This can be achieved, for example, by integrating different cell or organoid types (assembloids), or by using extracellular matrix (ECM) extracts for improving organoid culturing and enhancing microenvironment properties, or engineered ECM-mimicking hydrogels and scaffolds to generate tissue engineered miniaturized constructs. By recreating many of the cell-cell and cell-matrix interactions found in native tissues, as well as by providing the proper biophysical and biochemical stimuli to cells mimicking the in vivo microenvironment, these complex 3D cultures provide more physiologically accurate models than traditional 2D, monolayer or spheroid cultures, making them an attractive replacement for or addition to animal models in drug development and testing by pharmaceutical companies.The goal of this Research Topic titled "3D-Engineered Organoids for Modelling Tissue Development and Precision Medicine" is to disseminate critical review on the state-of-the art and original research articles on emerging approaches to develop innovative 3D-engineered organoid models.Lampart et al. provide a comprehensive review on the advancement of organoid models starting from the most common 3D systems to cover more complex, multilayered 3D structures, such as assembloids, gastruloids and ETiX embryoids. Authors highlight the potential of these complex 3D systems for disease modelling, particularly in the context of cancer, by using both patient-derived cells or genetic manipulation tools to recapitulate tumorigenesis in vitro. They also highlight developments in high-throughput organoid culturing systems and analysis tools to take full advantage or organoid accessible model, providing examples of culture alternatives to make them compatible with liquid-handling robots, and high-content screening, through the development of automated pipelines for image-based and omic-based analyses. They also summarize the potential of machine learning and computational modelling to process large multidimensional datasets obtained from the high-content screening, including the automated processing of imaging data.The two other reviews presented next cover more specific aspects on lung organoids and organoids of the gastrointestinal tract. The lung is a complex organ exposed to significant mechanical loads since fetal development. Recapitulating these stimuli in vitro is key to fully understand disease pathogenesis and identify therapeutical targets for lung regeneration. In this context, Shao et al. showcase the potential of lung organoids as a platform to investigate the underappreciated impact of biophysical and biomechanical properties in enhancing lung organoid complexity and functionality, and ultimately provide new insight into embryonic lung development and pulmonary distal disease pathogenesis. Technological solutions to improve functionality include the use of microfluidics, and scaffolds derived from decellularized lungs of animal or human origin that maintain the in vivo architecture of the lung ECM, which is significantly altered in many chronic lung diseases. Along the same line, Benedetti et al. provide a review on the progresses in human organoid engineering applied to the gastrointestinal tract (esophagus, stomach, and intestine). They present an overview of the advances of tissue engineering in animal systems, concerning novel materials and scaffolds to be combined with a variety of cell types to reconstitute a viable surrogate for implantation, while providing biophysical and biochemical stimuli relevant to these organs. Specifically, they discuss the engineering details for developing esophagus, stomach, and intestine organoids and tissue-engineered constructs. They cover aspects related to cell genetic engineering, niche modifications, which span from medium composition to ECM composition, and microarchitecture bioprinting, as well as the advancements made in microfluidic devices and organon-a-chip systems.Lastly, in an original research article, Decoene et al. report the development of an engineered model of bone-forming callus organoids amenable to industrial scale-up and automation, which also facilitates the implementation of non-invasive imaging and the use of quality control parameters based on secreted biomarkers. They perform an in-depth comparison of transcriptional changes during in vitro differentiation of human periosteum-derived cell (hPDCs) aggregates into cartilaginous microtissues cultured in a standard medium versus a xeno-free equivalent medium. They highlight an increased microtissue homogeneity with no uncontrolled fusion of microtissues, that might affect the diffusion of oxygen, nutrients, and growth factors leading to a reduced quality profile of the implant as an end tissue product. In addition, they assessed the bone-forming potential of these microtissues assembled into larger meso-tissues structures ectopically in vivo.In summary, this Research Topic comprises both novel research and review articles relating to the most recent advances in human physiopathologically-relevant in vitro modelling systems. A common factor highlighted in the contributed works is the complementarity between the cell culture system itself and the supportive technologies around it, both experimental and computational.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wenyiboy发布了新的文献求助50
1秒前
lileely完成签到 ,获得积分10
1秒前
1秒前
30完成签到,获得积分10
2秒前
cen完成签到,获得积分10
2秒前
5秒前
爆米花的应助被单薄丹翠采纳,获得10
6秒前
xuan发布了新的文献求助10
6秒前
8秒前
lijiahiui发布了新的文献求助10
8秒前
生椰拿铁完成签到 ,获得积分10
8秒前
9秒前
茶清味完成签到,获得积分20
10秒前
Dr_Seurin完成签到,获得积分10
11秒前
烟花的应助被Elient_采纳,获得30
11秒前
anugraphics完成签到,获得积分10
11秒前
希望天下0贩的0的应助被葡萄采纳,获得10
12秒前
Owen的应助被MaFY采纳,获得10
13秒前
15秒前
缥缈静珊发布了新的文献求助10
16秒前
19秒前
21秒前
星辰大海的应助被缥缈静珊采纳,获得10
27秒前
打打的应助被茶清味采纳,获得10
30秒前
富富裕发布了新的文献求助10
30秒前
大个的应助被zy采纳,获得10
32秒前
37秒前
科目三的应助被MaFY采纳,获得10
39秒前
YYMY2022完成签到,获得积分10
41秒前
傲娇访风完成签到,获得积分10
42秒前
44秒前
激情的菲音完成签到,获得积分10
44秒前
8564523完成签到,获得积分10
46秒前
传奇3的应助被富富裕采纳,获得10
47秒前
47秒前
LJS完成签到,获得积分10
50秒前
MaFY发布了新的文献求助10
51秒前
zy发布了新的文献求助10
53秒前
俭朴山灵完成签到 ,获得积分0
54秒前
54秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Mathematical models in hydrology 1000
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Erzählte Gnade 500
Butadiene hydroxytelechelic oligomers PBHT 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8083818
求助须知:如何正确求助?哪些是违规求助? 9498682
关于积分的说明 21408113
捐赠科研通 7652127
什么是DOI,文献DOI怎么找? 3402377
关于科研通互助平台的介绍 2531350
邀请新用户注册赠送积分活动 2440948